Cargando…
Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study
OBJECTIVE: To evaluate the effects of metformin use on the survival of inoperable non-small cell lung cancer (NSCLC) patients with diabetes using the Taiwanese National Health Insurance Research Database. RESEARCH DESIGN AND METHODS: In total, 7,620 patients were eligible in this study, among them,...
Autores principales: | Chuang, Min-Chun, Yang, Yao-Hsu, Tsai, Ying-Huang, Hsieh, Meng-Jer, Lin, Yu-Ching, Lin, Chin-Kuo, Chen, Pau-Chung, Yang, Tsung-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766148/ https://www.ncbi.nlm.nih.gov/pubmed/29329345 http://dx.doi.org/10.1371/journal.pone.0191129 |
Ejemplares similares
-
The association of aspirin use with overall survival of patients with inoperable non-small cell lung cancer: a retrospective study
por: Chuang, Min-Chun, et al.
Publicado: (2021) -
Metformin Prolongs Survival in Type 2 Diabetes Lung Cancer Patients With EGFR-TKIs
por: Hung, Ming-Szu, et al.
Publicado: (2019) -
Low cardiac dose and neutrophil-to-lymphocyte ratio predict overall survival in inoperable esophageal squamous cell cancer patients after chemoradiotherapy
por: Ho, Yu-Chieh, et al.
Publicado: (2021) -
The potential adjunctive benefit of adding metformin to standard treatment in inoperable cancer patients: a meta-analysis of randomized controlled trials
por: Wu, Zhonghua, et al.
Publicado: (2020) -
Impact of tumor size on outcome after stereotactic body radiation therapy for inoperable hepatocellular carcinoma
por: Kuo, Hsing-Tao, et al.
Publicado: (2017)